Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03432832 · ClinicalTrials.gov registry record · NA

Emotion Awareness and Skills Enhancement Program

A NA study, sponsored by University of Pittsburgh.

Completed
Registry status
NA
Development phase
113
Enrollment target

NCT03432832: Completed NA study, sponsored by University of Pittsburgh.

NCT03432832 is a NA study that has completed, run by University of Pittsburgh. The registered enrollment target is 113 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03432832, a NA study, has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
NA
Development phase
113 participants
Enrollment target

Study Summary

This project will address impaired emotion regulation in adolescents with ASD (autism spectrum disorder). There are no evidence-based interventions to improve emotion regulation (ER) in this population, yet poor emotion regulation often leads to maladaptive behavior and substantially impedes capacity to learn and function across all life settings, and reduce their quality of life and that of their families. The primary objective of this study is to formally evaluate efficacy of EASE via a sufficiently powered, two-site randomized-controlled trial (RCT).

Primary Outcome

The CGI-I will be used as a measure of overall improvement. The CGI-I (Improvement) scale was designed to measure overall symptomatic change at a specific time as compared to baseline that is completed by a rater who is blind to treatment assignment. Scores range from 1 (Very Much Improved) to 4 (Unchanged) to 7 (Very Much Worse). It is only a single item, and lower scores indicate more improvement.

Interventions

  • BEHAVIORAL Supportive Therapy
  • BEHAVIORAL EASE

Trial Details

FieldValue
Enrollment Target 113 participants
Start Date 2018-01-30
Est. Completion 2024-07-30
Phase NA
University of Pittsburgh

1,238 total trials

What the finished NCT03432832 record still lists

NCT03432832 is an interventional study that assigns participants to a tested intervention. The registered 113 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).

The record links to 0 conditions, and to 2 interventions - of which Supportive Therapy is the first listed.

NCT03432832 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03432832 about?

NCT03432832 is a clinical study titled "Emotion Awareness and Skills Enhancement Program". This project will address impaired emotion regulation in adolescents with ASD (autism spectrum disorder). There are no evidence-based interventions to improve emotion regulation (ER) in this population, yet poor emotion regulation often leads to maladaptive behavior and substantially impedes capacit...

What is the current status of trial NCT03432832?

This trial is currently completed. It is a NA study. The enrollment target is 113 participants. The study started on 2018-01-30. Estimated completion is 2024-07-30.

What interventions are being tested in trial NCT03432832?

The interventions under investigation include: Supportive Therapy (BEHAVIORAL), EASE (BEHAVIORAL).

Who is sponsoring clinical trial NCT03432832?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03432832's enrollment target sits among peer trials

113 813th of 2000 higher than 1,188 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00748254 · 113 participants

    Laser-based Photoacoustic Tomography of Human Inflammatory Arthritis

  • NCT04753190 · 113 participants · NA

    Light Timing Study

  • NCT05799248 · 113 participants · Phase 3

    Role of rhPSMA-7.3 PET/CT Imaging in Men With High-Risk Prostate Cancer Following Conventional Imaging and Associated Changes in Medical Management

  • NCT07216105 · 113 participants · Phase 1

    FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03432832, the US trial registry maintained by the National Library of Medicine. NCT03432832 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.